Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan E Shaw

Showing results (31-40 of 449) with videos related to

Pageof 45
Sort By:
BMJ Open|March 7, 2023
Prediction of cardiovascular death and non-fatal cardiovascular events by the Kidney age-Chronological age Difference (KCD) score in men and women of different ages in a community-based cohortDuncan J Campbell, Dianna J Magliano, Jonathan E Shaw
The New England Journal of Medicine|February 26, 2015
Glycemic control and excess mortality in type 1 diabetesDianna J Magliano, Jessica L Harding, Jonathan E Shaw
Endocrinology and Metabolism Clinics of North America|May 26, 2004
The metabolic syndrome: prevalence in worldwide populationsAdrian J Cameron, Jonathan E Shaw, Paul Z Zimmet
Diabetes Care|November 21, 2020
Comment on Zhou et al. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes Care 2020;43:1593-1616Thirunavukkarasu Sathish, Jonathan E Shaw, Brian Oldenburg, et al.
Diabetes Care|June 14, 2022
Cardiorenal Complications in Young-Onset Type 2 Diabetes Compared Between White Americans and African AmericansSanjoy K Paul, Jonathan E Shaw, Peter Fenici, et al.
Diabetes, Obesity & Metabolism|August 4, 2020
Cardiometabolic risk factor control in black and white people in the United States initiating sodium-glucose co-transporter-2 inhibitors: A real-world studyOlga Montvida, Subodh Verma, Jonathan E Shaw, et al.
Handbook of Clinical Neurology|November 21, 2014
Epidemiology of polyneuropathy in diabetes and prediabetesDan Ziegler, Nikolaos Papanas, Aaron I Vinik, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2026
Predicting complications for diabetes in South Asians: Beyond conventionBeryl Lin, Lee-Ling Lim, Viswanathan Mohan, et al.
Diabetes Research and Clinical Practice|October 26, 2023
Trends of hospitalisation for cardiovascular diseases among people with diabetes in AustraliaBerhanu Elfu Feleke, Jedidiah Morton, Dianna Magliano, et al.
Diabetes, Obesity & Metabolism|March 15, 2018
Long-term sustainability of glycaemic achievements with second-line antidiabetic therapies in patients with type 2 diabetes: A real-world studyOlga Montvida, Jonathan E Shaw, Lawrence Blonde, et al.
Pageof 45

Showing results (31-40 of 449) with videos related to

Sort By:
Pageof 45
BMJ Open|March 7, 2023
Prediction of cardiovascular death and non-fatal cardiovascular events by the Kidney age-Chronological age Difference (KCD) score in men and women of different ages in a community-based cohortDuncan J Campbell, Dianna J Magliano, Jonathan E Shaw
The New England Journal of Medicine|February 26, 2015
Glycemic control and excess mortality in type 1 diabetesDianna J Magliano, Jessica L Harding, Jonathan E Shaw
Endocrinology and Metabolism Clinics of North America|May 26, 2004
The metabolic syndrome: prevalence in worldwide populationsAdrian J Cameron, Jonathan E Shaw, Paul Z Zimmet
Diabetes Care|November 21, 2020
Comment on Zhou et al. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Diabetes Care 2020;43:1593-1616Thirunavukkarasu Sathish, Jonathan E Shaw, Brian Oldenburg, et al.
Diabetes Care|June 14, 2022
Cardiorenal Complications in Young-Onset Type 2 Diabetes Compared Between White Americans and African AmericansSanjoy K Paul, Jonathan E Shaw, Peter Fenici, et al.
Diabetes, Obesity & Metabolism|August 4, 2020
Cardiometabolic risk factor control in black and white people in the United States initiating sodium-glucose co-transporter-2 inhibitors: A real-world studyOlga Montvida, Subodh Verma, Jonathan E Shaw, et al.
Handbook of Clinical Neurology|November 21, 2014
Epidemiology of polyneuropathy in diabetes and prediabetesDan Ziegler, Nikolaos Papanas, Aaron I Vinik, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2026
Predicting complications for diabetes in South Asians: Beyond conventionBeryl Lin, Lee-Ling Lim, Viswanathan Mohan, et al.
Diabetes Research and Clinical Practice|October 26, 2023
Trends of hospitalisation for cardiovascular diseases among people with diabetes in AustraliaBerhanu Elfu Feleke, Jedidiah Morton, Dianna Magliano, et al.
Diabetes, Obesity & Metabolism|March 15, 2018
Long-term sustainability of glycaemic achievements with second-line antidiabetic therapies in patients with type 2 diabetes: A real-world studyOlga Montvida, Jonathan E Shaw, Lawrence Blonde, et al.
Pageof 45